Publication: Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids
Issued Date
2010-03-01
Resource Type
ISSN
00099120
Other identifier(s)
2-s2.0-76749103354
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Biochemistry. Vol.43, No.4-5 (2010), 424-429
Suggested Citation
Ruchaneekorn W. Kalpravidh, Noppadol Siritanaratkul, Praphaipit Insain, Ratiya Charoensakdi, Narumol Panichkul, Suneerat Hatairaktham, Somdet Srichairatanakool, Chada Phisalaphong, Eliezer Rachmilewitz, Suthat Fucharoen Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids. Clinical Biochemistry. Vol.43, No.4-5 (2010), 424-429. doi:10.1016/j.clinbiochem.2009.10.057 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/28779
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids
Abstract
Objectives: To evaluate the hematological profile, oxidative stress, and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids for 12 months. Design and methods: Twenty-one β-thalassemia/Hb E patients were given 2 capsules of 250 mg each of curcuminoids (a total of 500 mg) daily for 12 months. Blood was collected every 2 months during treatment and 3 months after withdrawal and was determined for complete blood count, malonyldialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), reduced glutathione (GSH) in red blood cells (RBC), and non-transferrin bound iron (NTBI) in serum. Results: The increased oxidative stress in β-thalassemia/Hb E patients was shown by higher levels of MDA, SOD, GSH-Px in RBC, serum NTBI, and lower level of RBC GSH. Curcuminoids administration resulted in improvement of all the measured parameters as long as they were administered. After 3 months withdrawal of treatment, all parameters returned close to baseline levels. Conclusion: Curcuminoids may be used to ameliorate oxidative damage in patients with β-thalassemia/Hb E disease. © 2009 The Canadian Society of Clinical Chemists.